GPT and hepatocellular carcinoma: In general, this is the first comprehensive study to report that the GPT1 is closely associated with the regulation role of BBR in metabolic reprogramming of HCC by alanine–glucose conversion, which may be developed as a potential new molecular target for the treatment of HCC.